Chondroprotection and the Prevention of Osteoarthritis Progression of the Knee

Abstract

Background:

Structure-modifying medications or nutraceuticals may be an effective treatment for osteoarthritis. This study identified 12 treatments that may possess chondroprotective properties: oral glucosamine; chondroitin; nonsteroidal anti-inflammatory drugs (NSAIDs); polyunsaturated fatty acids; S-adenosylmethionine; avocado and soybean unsaponifiable fractions; methylsulfonylmethane; vitamins C, D, and E; intra-articular injections of hyaluronic acid; and platelet-rich plasma (PRP).

Purpose:

To perform a systematic review of randomized controlled trials for the effectiveness of each agent in preserving articular cartilage of the knee and delaying the progression of osteoarthritis.

Study Design:

Systematic review; Level of evidence, 2.

Methods:

A literature search was performed using PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials. Searches were performed using “treatment,” “osteoarthritis,” and “knee” as keywords. Selection criteria included randomized controlled trials of ≥12 months, with a placebo control, measuring radiographic changes in joint space width, cartilage volume, or radiographic progression of osteoarthritis. The primary outcome was changes in joint integrity measures.

Results:

A total of 3514 studies were identified from the initial search, 13 of which met inclusion criteria. Treatment with chondroitin sulfate showed a significant reduction in cartilage loss in 3 of 4 studies identified compared with placebo. Two of 3 trials identified for glucosamine also reported significant structural effects relative to placebo. Intra-articular hyaluronic acid was effective in lowering the rate of cartilage loss in only 1 of 3 studies identified versus placebo. Of the 6 studies identified for NSAIDs, vitamin E, and vitamin D, none showed any structural effect compared with placebo. No studies were found that met the inclusion criteria for polyunsaturated fatty acids, S-adenosylmethionine, avocado and soybean unsaponifiable fractions, methylsulfonylmethane, vitamin C, or PRP.

Conclusion:

For patients with or at risk for osteoarthritis, the use of glucosamine and chondroitin sulfate may serve as a nonoperative means to protect joint cartilage and delay osteoarthritis progression. Hyaluronic acid injections showed variable efficacy, while NSAIDs and vitamins E and D showed no effect on osteoarthritis progression. The other agents evaluated had no evidence in the literature to support or refute their use for chondroprotection.

Keywords

knee articular cartilage chondroprotection nutraceutical

Get full access to this article

View all access options for this article.

References

Als-Nielsen

Chen

Gluud

Kjaergard

. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA. 2003;290(7):921-928.

Altman

Asch

Bloch

. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 1986;29(8):1039-1049.

Amin

LaValley

Guermazi

. The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis. Arthritis Rheum. 2005;52(10):3152-3159.

Bergink

Uitterlinden

Van Leeuwen

. Vitamin D status, bone mineral density, and the development of radiographic osteoarthritis of the knee: the Rotterdam Study. J Clin Rheumatol. 2009;15(5):230-237.

Buckland-Wright

. Review of the anatomical and radiological differences between fluoroscopic and non-fluoroscopic positioning of osteoarthritic knees. Osteoarthritis Cartilage. 2006;14(Suppl A):A19-A31.

Buckland-Wright

MacFarlane

Lynch

Jasani

. Quantitative microfocal radiography detects changes in OA knee joint space width in patients in placebo controlled trial of NSAID therapy. J Rheumatol. 1995;22(5):937-943.

Canter

Wider

Ernst

. The antioxidant vitamins A, C, E and selenium in the treatment of arthritis: a systematic review of randomized clinical trials. Rheumatology (Oxford). 2007;46(8):1223-1233.

Christensen

Bartels

Astrup

Bliddal

. Symptomatic efficacy of avocado-soybean unsaponifiables (ASU) in osteoarthritis (OA) patients: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage. 2008;16(4):399-408.

Cole

Seroyer

Filardo

Bajaj

Fortier

. Platelet-rich plasma: where are we now and where are we going? Sports Health. 2010;2(3):203-210.

10.

Dieppe

Cushnaghan

Jasani

McCrae

Watt

. A two-year, placebo-controlled trial of non-steroidal anti-inflammatory therapy in osteoarthritis of the knee joint. Br J Rheumatol. 1993;32(7):595-600.

11.

Ezaki

Hashimoto

Hosokawa

Ishimi

. Assessment of safety and efficacy of methylsulfonylmethane on bone and knee joints in osteoarthritis animal model. J Bone Miner Metab. 2013;31(1):16-25.

12.

Fam

Kontopoulou

Bryant

. Effect of concentration and molecular weight on the rheology of hyaluronic acid/bovine calf serum solutions. Biorheology. 2009;46(1):31-43.

13.

Goldring

Otero

Tsuchimochi

Ijiri

. Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism. Ann Rheum Dis. 2008;67(Suppl 3):iii75-iii82.

14.

Heidari

Hajian-Tilaki

. Association between serum vitamin D deficiency and knee osteoarthritis. Int Orthop. 2011;35(11):1627-1631.

15.

Hochberg

. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. Osteoarthritis Cartilage. 2010;18(Suppl 1):S28-S31.

16.

Jackson

Plaas

Sandy

. The human pharmacokinetics of oral ingestion of glucosamine and chondroitin sulfate taken separately or in combination. Osteoarthritis Cartilage. 2010;18(3):297-302.

17.

Jadad

Moore

Carroll

. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.

18.

Jevsevar

Brown

Jones

. Treatment of Osteoarthritis of the Knee: Evidence Based Guideline. 2nd ed. Rosemont, Illinois: American Academy of Orthopaedic Surgeons; 2013.

19.

Kahan

Uebelhart

De Vathaire

Delmas

Reginster

. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2009;60(2):524-533.

20.

Kellgren

Lawrence

. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494-502.

21.

Kotlarz

Gunnarsson

Fang

Rizzo

. Insurer and out-of-pocket costs of osteoarthritis in the US: evidence from national survey data. Arthritis Rheum. 2009;60(12):3546-3553.

22.

Lawrence

Felson

Helmick

. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum. 2008;58(1):26-35.

23.

Lee

Woo

Choi

Song

. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int. 2010;30(3):357-363.

24.

Listrat

Ayral

Patarnello

. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage. 1997;5(3):153-160.

25.

Lopez

. Nutritional interventions to prevent and treat osteoarthritis, part I: focus on fatty acids and macronutrients. PM R. 2012;4(5 Suppl):S145-S154.

26.

Lopez

. Nutritional interventions to prevent and treat osteoarthritis, part II: focus on micronutrients and supportive nutraceuticals. PM R. 2012;4(5 Suppl):S155-S168.

27.

Lotz

. Cytokines in cartilage injury and repair. Clin Orthop Relat Res. 2001;(391 Suppl):S108-S115.

28.

Martel-Pelletier

Boileau

Pelletier

Roughley

. Cartilage in normal and osteoarthritis conditions. Best Pract Res Clin Rheumatol. 2008;22(2):351-384.

29.

Mazzuca

Brandt

Katz

Lane

Buckwalter

. Comparison of quantitative and semiquantitative indicators of joint space narrowing in subjects with knee osteoarthritis. Ann Rheum Dis. 2006;65(1):64-68.

30.

McAlindon

LaValley

Schneider

. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA. 2013;309(2):155-162.

31.

Michel

Stucki

Frey

. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum. 2005;52(3):779-786.

32.

Pavelka

Gatterova

Olejarova

Machacek

Giacovelli

Rovati

. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002;162(18):2113-2123.

33.

Pelletier

Raynauld

Berthiaume

. Risk factors associated with the loss of cartilage volume on weight-bearing areas in knee osteoarthritis patients assessed by quantitative magnetic resonance imaging: a longitudinal study. Arthritis Res Ther. 2007;9(4):R74.

34.

Pham

Le Henanff

Ravaud

Dieppe

Paolozzi

Dougados

. Evaluation of the symptomatic and structural efficacy of a new hyaluronic acid compound, NRD101, in comparison with diacerein and placebo in a 1 year randomised controlled study in symptomatic knee osteoarthritis. Ann Rheum Dis. 2004;63(12):1611-1617.

35.

Poolsup

Suthisisang

Channark

Kittikulsuth

. Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials. Ann Pharmacother. 2005;39(6):1080-1087.

36.

Reginster

Deroisy

Rovati

. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001;357(9252):251-256.

37.

Rutjes

Juni

da Costa

Trelle

Nuesch

Reichenbach

. Viscosupplementation for osteoarthritis of the knee: a systematic review and meta-analysis. Ann Intern Med. 2012;157(3):180-191.

38.

Saklatvala

. Inflammatory signaling in cartilage: MAPK and NF-kappaB pathways in chondrocytes and the use of inhibitors for research into pathogenesis and therapy of osteoarthritis. Curr Drug Targets. 2007;8(2):305-313.

39.

Sawitzke

Shi

Finco

. Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis. 2010;69(8):1459-1464.

40.

Uebelhart

Malaise

Marcolongo

. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage. 2004;12(4):269-276.

41.

van den Berg

. Osteoarthritis year 2010 in review: pathomechanisms. Osteoarthritis Cartilage. 2011;19(4):338-341.

42.

Vlad

LaValley

McAlindon

Felson

. Glucosamine for pain in osteoarthritis: why do trial results differ? Arthritis Rheum. 2007;56(7):2267-2277.

43.

Wang

Hall

Hanna

. Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial. BMC Musculoskelet Disord. 2011;12:195.

44.

Wluka

Stuckey

Brand

Cicuttini

. Supplementary vitamin E does not affect the loss of cartilage volume in knee osteoarthritis: a 2 year double blind randomized placebo controlled study. J Rheumatol. 2002;29(12):2585-2591.

45.

Wluka

Wolfe

Stuckey

Cicuttini

. How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis? Ann Rheum Dis. 2004;63(3):264-268.

46.

Zhang

Nuki

Moskowitz

. OARSI recommendations for the management of hip and knee osteoarthritis, part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage. 2010;18(4):476-499.